The synergy of multiphoton fluorescence imaging (MP-FI) and magnetic resonance imaging (MRI) provides an imaging platform with high resolution and unlimited penetration depth for early disease detection. Herein, two kinds of terpyridine-Mn(II) complexes ( and possessing seven and six coordination modes, respectively, were designed rationally for photodynamic therapy (PDT) guided by MP-FI/MRI. The complexes obtain different multiphoton fluorescence/magnetic resonance properties by adjusting the number of terpyridine ligands. Among them, exhibits the following superiorities: (1) The optimal three-photon excitation wavelength of falls at 1450 nm (NIR-II), which brings high sensitivity and deep tissue penetration in MP-FI. (2) has effective longitudinal relaxation efficiency ( = 2.6 m M s), which can be used for -weighted MRI, overcoming the problems of limited tissue penetration depth and low spatial resolution. (3) generates endogenous O under irradiation by 808 nm light, thereby enhancing the PDT effect in vitro and in vivo. To the best of our knowledge, the complex is the first complex to guide PDT through MP-FI/MRI, providing a blueprint for accurate and effective early detection and timely treatment of the complex in the early stages of cancer.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.inorgchem.2c01603 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!